Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis published directly by a partner lab. Filter by peptide, vendor, lab, or test coverage. Each row links to the verified record — not a vendor-hosted copy.
← Swipe to see more columns →
| Vendor | Peptide | Lot | Lab | Purity | Tests | Provenance | Tested | |
|---|---|---|---|---|---|---|---|---|
| BioLongevity Labs | FLGR242, B-Complex (Cyanocobalamin (Vit B12), Pyridoxine (Vit B6)) | 90-3-46154 | MDx BioAnalytical Laboratory | 99.74% | MSLAL |
| Vendor-published |
| 2026-05-14 |
| View |
| Skye Peptides | KLOW26-80-003 | Janoshik Analytical | — | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-05-14 | View |
| BioLongevity Labs | 7-3-46154 | MDx BioAnalytical Laboratory | 99.75% | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| BioLongevity Labs | 18-3-46154 | MDx BioAnalytical Laboratory | 99.78% | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| BioLongevity Labs | 3-3-46154 | MDx BioAnalytical Laboratory | 99.78% | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Verified Peptides | GL05260670E | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Verified Peptides | TB042609101 | Janoshik Analytical | 99.02% | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Verified Peptides | IPA05261110K | Janoshik Analytical | 99.84% | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Verified Peptides | KL04260380C | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Verified Peptides | IPCJ05260920I | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Verified Peptides | IPCJ052609201 | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Mile High Compounds | Acetric Acidlow conf | ACE-010-MH-01 | Vanguard Laboratory | — | MSLALUSP<71>HM | Vendor-published | 2026-05-13 | View |
| Peptidology | 1673 | Vanguard Laboratory | 99.17% | MSLALUSP<71>HM | Confirmed by Vanguard Laboratory | 2026-05-13 | View |
| Sunrise Bioresearch | MTC10MAY26-01 | ILS Labs | 99.98% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-12 | View |
| Sunrise Bioresearch | GHK100MAY26-01 | ILS Labs | 99.10% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-12 | View |
| Sunrise Bioresearch | CP10MAY26-01 | ILS Labs | 99.57% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-12 | View |
| Sunrise Bioresearch | GLP320MAY26-01 | ILS Labs | 99.89% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-12 | View |
| Sunrise Bioresearch | NAD500MAY26-01 | ILS Labs | 97.54% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-12 | View |
| NG Peptide | TIC336-01 | ILS Labs | 99.92% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-12 | View |
| Kimera Chems | Myostatin inhibitor D-peptide (MID-35) | KC-MID-BLK1 | MZ Biolabs | 99.37% | MSLALUSP<71>HM | Vendor-published | 2026-05-12 | View |
| Kimera Chems | Citicoline | KC-CDC-02 | NuMega Resonance Labs | — | MSLALUSP<71>HM | Vendor-published | 2026-05-12 | View |
| Verified Peptides | LL05260305C | Janoshik Analytical | 99.64% | MSLALUSP<71>HM | Vendor-published | 2026-05-12 | View |
| Verified Peptides | CJD06261105J | Janoshik Analytical | 99.46% | MSLALUSP<71>HM | Vendor-published | 2026-05-12 | View |
| Verified Peptides | FTB0626Q510E | Janoshik Analytical | 99.95% | MSLALUSP<71>HM | Vendor-published | 2026-05-12 | View |
| Verified Peptides | FTB06260510E | Janoshik Analytical | 99.95% | MSLALUSP<71>HM | Vendor-published | 2026-05-12 | View |
| Kimera Chems | KC-NSI-03 | MZ Biolabs | 99.76% | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | GL05260670E | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | KIS04260310C | Janoshik Analytical | 99.94% | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | BP0526121OJ | Janoshik Analytical | 99.92% | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | KL04260380C | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | PT03261310J | Janoshik Analytical | 99.78% | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | — | Janoshik Analytical | 99.94% | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | KL04260380C | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Verified Peptides | BP05261210J | Janoshik Analytical | 99.92% | MSLALUSP<71>HM | Vendor-published | 2026-05-11 | View |
| Crush Research | NAD+low conf | CR-NJ500-0309-1 | ILS Labs | 99.44% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-11 | View |
| Crush Research | Tesamorelinlow conf | CR-TSM20-0307-1 | ILS Labs | 99.47% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-11 | View |
| Crush Research | MOTS-clow conf | CR-MTS10-0309-1 | ILS Labs | 99.91% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-11 | View |
| Crush Research | EPITALONlow conf | CRET-50-0212-1 | ILS Labs | 99.08% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-11 | View |
| Crush Research | PT-141low conf | CRPT-10-2605-1 | ILS Labs | 99.93% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-11 | View |
| Glacier Aminos | TIR20GA-04 | Kovera Labs | 99.85% | MSLALUSP<71>HM | Vendor-uploaded · pending lab verification | 2026-05-11 | View |
| Prime Peptides | 3302026RT | Janoshik Analytical | 99.20% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-05-11 | View |
| Prime Peptides | 3292026CJI | Janoshik Analytical | — | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-05-11 | View |
| Skye Peptides | TESA26-20-004 | Janoshik Analytical | 99.23% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-05-11 | View |
| Skye Peptides | AOD26-06-002 | Janoshik Analytical | 99.75% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-05-11 | View |
| Skye Peptides | TESA26-10-002 | Janoshik Analytical | 99.24% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-05-11 | View |
| Sunrise Bioresearch | BPC10MAY26-02 | ILS Labs | 99.28% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-10 | View |
| Sunrise Bioresearch | BPC10MAY26-01 | ILS Labs | 99.75% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-10 | View |
| NG Peptide | BPTB10-4 | ILS Labs | 99.31% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-10 | View |
| NG Peptide | TSM20-3 | ILS Labs | 99.48% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-10 | View |
| NG Peptide | ND500-4 | ILS Labs | 99.83% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-05-10 | View |
Disclosed Labs